Danaher shares jump 7% as the turnaround in biotech spending finally arrives


In this photo illustration, a Danaher Corporation logo seen displayed on a tablet. 
Igor Golovnov | SOPA Images | Lightrocket | Getty Images

Shares of Danaher popped more than 7% on Tuesday after the life sciences company delivered beats across its three main businesses — a sign the long-awaited turnaround in the biotech industry is finally here.

Articles You May Like

Trump Media stock falls 10% after posting $327.6 million loss in first quarter
Peloton shares drop after it announces refinancing to stave off cash crunch
As their customers age, Macy’s, Kohl’s and Nordstrom are chasing younger shoppers
We maintain our rating on Ford shares after a bullish Street initiation
Nvidia and 2 other portfolio stocks report earnings next week. Here’s what we want to see from each